Skip to main content
Mi-Ok Kim on Muck Rack

Mi-Ok Kim

As seen in: Nature, Wiley Online Library, JAMA Network, Cell Press, The Lancet, Pediatrics, Diabetes Magazine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Mi-Ok

Contact Mi-Ok, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Breast Cancer Survival in Asian American Patients

|
By Scarlett Lin Gomez, Julie Von Behren, Valerie McGuire, Mi-Ok Kim, Salma Shariff-Marco, Katherine Lin, Iona Cheng, Marilyn L. Kwan, Anna Wu, Esther M John, Allison W. Kurian, Jocelyn Koo, Janise M. Roh, Isaac J. Ergas, Christine B. Ambrosone, Brittany N. Morey, Lawrence H. Kushi, Song T. Yao, Lenora Loo, Lia D’addario, Esperanza Castillo
| JAMA Network Verified
Breast Cancer Survival in Asian American Patients Supplement 1. eTable 1. Description of covariates for characteristics of breast cancer survival studies included in the Asian American Resiliency and Cancer study eTable 2. Hazard ratios and 95% CIs for overall mortality and breast cancer-specific mortality, stratified by summary stage for Asian American ethnicity compared to non-Latina White females with breast cancer in the Asian American Resiliency and Cancer study eTable 3.
Open in Who Shared Issue with article?

Closing the screening gap but not the writing gap: a two-topic evaluation of LLMs for systematic reviews and meta-analyses in hepatology

|
By Yuntao Zou, Iris Kim Verified, NAN GAO, Michelle Li Verified, Mi-Ok Kim, Jin Ge
| Nature Verified
Abstract Systematic reviews are essential but labor-intensive. We evaluated LLM-assisted literature screening and drafting in two hepatology topics: carvedilol in compensated cirrhosis and anticoagulation in portal vein thrombosis. For each topic, we searched PubMed, Cochrane, and EMBASE. A few-shot prompt with explicit inclusion/exclusion criteria was used to screen titles and abstracts, with results compared to manual review.
Open in Who Shared Issue with article?

Safety and efficacy of a STAT3-targeted cyclic oligonucleotide: From murine models to a phase 1 clinical trial in pet cats with oral cancer

|
By Jennifer R. Grandis, Katherine A. Skorupski, Ning Cheng, Zhibin Cui, Hua Li, Liam C Woerner, Jovanka Gencel-Augusto, Yan Zeng, Jamie V. Shiah, Neil E. Bhola, Malabika Sen, Kelly Blum, Mi-Ok Kim, Daniel BasesNew YORK, Robert B. Rebhun, Hong Chang, Natalia F. Murad, Adam B. Olshen, Ellen Sparger, Daniel Johnson
| Cell Press Verified
Keywords STAT3 cyclic STAT3 decoy head and neck cancer oral cancer STAT3 inhibitor clinical trial feline oral cancer Get full text access Log in, subscribe or purchase for full access. References 1. Zou, S. ∙ Tong, Q. ∙ Liu, B. ... Targeting STAT3 in Cancer Immunotherapy Mol. Cancer. 2020; 19:145 2. Johnson, D.E. ∙ O'Keefe, R.A. ∙ Grandis, J.R. Targeting the IL-6/JAK/STAT3 signalling axis in cancer Nat. Rev. Clin. Oncol. 2018; 15:234-248 3. Kortylewski, M. ∙ Yu, H.
Open in Who Shared Issue with article?
See all 11 articles